药物动员与趋化因子定向募集间充质基质细胞至手术修复的肩袖
在大鼠肩袖修复模型中,比较三种趋化因子募集标记间充质基质细胞(MSC)至手术肩部的能力,并评估药物动员MSC对趋化因子定向募集及腱骨愈合的影响。MCP-1水凝胶募集的MSC最多,药物动员方案进一步增强MCP-1驱动的募集;该策略与腱骨界面静态和动态力学性能改善相关。
要点
- MCP-1水凝胶从循环中募集的MSC数量最多。
- 皮下BRL37344与AMD3100方案显著增强MCP-1驱动的MSC募集。
- 该治疗策略与腱骨界面静态和动态力学性能改善相关。
核心结论
- 内源性MSC可被药物动员至外周血,并通过局部递送MCP-1募集至肩袖修复部位。
- 该治疗策略与腱骨界面静态和动态力学性能改善相关。
研究设计与样本
- 研究为对照实验室研究,使用大鼠冈上肌腱离断及急性手术修复模型。
- 比较3种趋化因子(SDF-1β、MIP-3α和MCP-1)将光学标记的MSC从循环募集至手术肩部的能力。
- 评估β3肾上腺素受体激动剂(BRL37344)与CXCR4拮抗剂(AMD3100)联合药物动员MSC对趋化因子定向募集至肩部的影响。
- 评估该治疗策略对腱骨愈合的影响。
主要发现
- MCP-1负载水凝胶从循环中募集的MSC数量最多。
- 皮下BRL37344和AMD3100方案显著增强MCP-1驱动的MSC募集。
- 6周终点死后微型计算机断层扫描显示,局部MCP-1递送与骨小梁间距和表观矿物质密度显著降低、骨小梁数量显著增加相关,而药物MSC动员无显著影响。
- MCP-1递送与较低肌腱横截面积和松弛百分比显著增加相关(P = .006)。
- 药物MSC动员与峰值应力显著增加(P = .039)、弹性模量显著增加(P = .037)相关,平衡应力(P = .057)和极限应力(P = .058)增加未达统计学显著。
关键数值与推荐
- MCP-1负载水凝胶募集的MSC数量最多。
- BRL37344和AMD3100方案显著增强MCP-1驱动的MSC募集。
- MCP-1递送组松弛百分比显著增加(P = .006)。
- 药物MSC动员组峰值应力显著增加(P = .039),弹性模量显著增加(P = .037)。
- 药物MSC动员组平衡应力(P = .057)和极限应力(P = .058)增加未达统计学显著。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mesenchymal stromal cell (MSC) techniques represent a promising method to enhance the surgical repair of rotator cuff tears. To eliminate the resource-intensive process of cell isolation and culture expansion, a method to recruit endogenous MSCs was investigated in an established rat model of rotator cuff repair. HYPOTHESIS: MSCs can be pharmacologically mobilized from the peripheral blood and recruited to the operative rotator cuff to enhance tendon-bone healing. STUDY DESIGN: Controlled laboratory study. METHODS: The rat model of supraspinatus tendon detachment and acute surgical repair was used to compare the ability of 3 different chemokines (SDF-1β, MIP-3α, and MCP-1) to recruit optically labeled MSCs to the operative shoulder from circulation. Additional experimentation was undertaken to assess the effects of pharmacological MSC mobilization using a combination of a β3 adrenoreceptor agonist (BRL37344) and a CXCR4 antagonist (AMD3100) on chemokine-directed recruitment to the shoulder. Finally, the effects of this therapeutic strategy on tendon-bone healing were assessed. RESULTS: MCP-1-loaded hydrogels recruited the greatest number of MSCs from circulation. MCP-1-driven MSC recruitment was significantly enhanced by a regimen of subcutaneous BRL37344 and AMD3100. Postmortem micro-computed tomography imaging performed at a 6-week endpoint revealed that local MCP-1 delivery was associated with significant reductions in trabecular spacing and apparent mineral density, and a significant increase in trabecular number, while pharmacological MSC mobilization had no significant effects. MCP-1 delivery was associated with a lower tendon cross-sectional area and a significant increase in percent relaxation (P = .006). Pharmacological MSC mobilization was associated with significantly increased peak stress (P = .039), significantly increased elastic modulus (P = .037), and a nonsignificant increase in both equilibrium stress (P = .057) and ultimate stress (P = .058). Local MCP-1 delivery was associated with significant improvements in tenocyte morphology. CONCLUSION: Endogenous MSCs can be pharmacologically mobilized into peripheral blood and recruited to the site of rotator cuff repair via local delivery of MCP-1. This therapeutic strategy was associated with improvements in the static and dynamic mechanical properties of the tendon-bone interface. CLINICAL RELEVANCE: The healing of rotator cuff repairs represents an ongoing clinical challenge in orthopaedic surgery. This study demonstrates a method to use endogenous MSCs to enhance healing of the rotator cuff.
引用
- Baker KC, Fleischer M, Newton MD, et al. Pharmacologic Mobilization and Chemokine-Directed Recruitment of Mesenchymal Stromal Cells to the Surgically Repaired Rotator Cuff. Am J Sports Med. 2025. PMID: 40444728. doi:10.1177/03635465251341439
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。